**Core Concept**
2,3-Bisphosphoglycerate (2,3 DPG) is an organic phosphate that inhibits hemoglobin's oxygen-binding affinity, thereby facilitating oxygen delivery to tissues. Its concentration is influenced by various physiological and pathological conditions.

**Why the Correct Answer is Right**
2,3 DPG is produced in erythrocytes through the Rapoport-Luebering pathway, which is activated in response to an increase in 2,3 bisphosphoglycerate mutase activity, typically seen in conditions of low oxygen levels or anemia. This increase in 2,3 DPG concentration enhances the release of oxygen from hemoglobin to tissues. Inosine, a breakdown product of adenosine triphosphate (ATP), also stimulates 2,3 DPG production by activating the Rapoport-Luebering pathway. Hypoxia and anemia are characterized by reduced oxygen delivery, which triggers the production of 2,3 DPG. However, hypoxanthine, a product of purine metabolism, does not stimulate 2,3 DPG production.

**Why Each Wrong Option is Incorrect**
**Option A:** Anemia, characterized by a decrease in the number of red blood cells or their hemoglobin content, leads to an increase in 2,3 DPG concentration as a compensatory mechanism to enhance oxygen delivery.
**Option B:** Hypoxia, or a state of insufficient oxygen, triggers the production of 2,3 DPG to increase oxygen release from hemoglobin.
**Option C:** Inosine stimulates 2,3 DPG production by activating the Rapoport-Luebering pathway, which leads to an increase in 2,3 DPG concentration.

**Clinical Pearl / High-Yield Fact**
The increase in 2,3 DPG concentration in response to anemia or hypoxia is a compensatory mechanism to enhance oxygen delivery to tissues, highlighting the body's ability to adapt to physiological stress.

**✓ Correct Answer:** D. Hypoxanthine.